Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

2.6K

Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy

Madaswamy S Muthu1, Abhishesh Kumar Mehata1, Matte Kasi Viswanadh1

  • 1Department of Pharmaceutics, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh 221005, India.

Nanomedicine (London, England)
|March 1, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
biolabelscancer nanotechnologydrug targetingmolecular biomaterialsmolecular imagingnanoprobestheranostics

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.7K
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

814

Related Experiment Videos

Last Updated: Mar 7, 2026

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

2.6K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.7K
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

814

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

Articles linked to this work by shared authors, journal, and citation graph.

3-Nitropropionic Acid-Induced Huntington's Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model Gaps, and Future Directions.

Molecular neurobiology·2026

Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation.

Nanotheranostics·2026

Doxorubicin-loaded polyvinyl alcohol-chitosan-based nanofibers for antimicrobial therapy and real-time in-vivo imaging.

Therapeutic delivery·2026

Tamoxifen-loaded TPGS-PLGA nanoplatform for breast cancer therapy: insights into drug delivery, distribution, treatment efficacy, and ultrasound/photoacoustic imaging.

Nanomedicine (London, England)·2026

Photoacoustic imaging and biodistribution analysis of trimethyl chitosan-stabilized ZnO nanoparticles embedded in nanofiber scaffolds for diabetic wound healing.

Nanomedicine : nanotechnology, biology, and medicine·2026

CRISPR/Cas9 genome editing-based preclinical theranostics, biomarkers and drug delivery systems for cancer applications.

International journal of biological macromolecules·2026

Understanding Mycobacterium tuberculosis host immune responses and identifying synergistic autophagy-inducing compounds as potential nanomedicines for tuberculosis treatment.

Nanomedicine (London, England)·2026

Ultrasound-responsive microencapsulated curcumin nanobubbles for treatment of mice rheumatoid arthritis and mechanistic insights based on single-cell Transcriptomics.

Nanomedicine (London, England)·2026

The protection of chitosan-coated triptolide-magnesium nanoparticles against intervertebral disc degeneration via MAPK signaling and mitophagy.

Nanomedicine (London, England)·2026

Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Nanomedicine (London, England)·2026

Glutathione-responsive gambogic acid-conjugated carboxymethyl chitosan/graphene quantum dot nanoparticles for chemo-photothermal-photodynamic synergistic therapy of drug-resistant breast cancer.

Nanomedicine (London, England)·2026

Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research.

Nanomedicine (London, England)·2026

Nanomedicine for pancreatitis therapy: mechanism-guided design and translational challenges.

International journal of pharmaceutics·2026

Enhanced transendothelial delivery of albumin-based carriers into tumors via macropinocytosis.

Journal of controlled release : official journal of the Controlled Release Society·2026

Farnesyltransferase Enables Modular Assembly of Dual-Functional Nanobody Conjugates for in Vivo Imaging of Inflammation.

Angewandte Chemie (International ed. in English)·2026

Pathogen-Mimetic Liposomes Customizing Protein Corona for Precision Glioblastoma Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Breast Cancer Therapy with Quantum Dots: NIR-II Image-Guided Interventions, Multimodal Treatment, and Translation.

Current medicinal chemistry·2026

Echocardiographic characteristics of new-onset methamphetamine-associated heart failure: a retrospective cohort study.

Echo research and practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us